Literature DB >> 13677819

Visual dysfunction, neurodegenerative diseases, and aging.

Gregory R Jackson1, Cynthia Owsley.   

Abstract

The four most common sight-threatening conditions in older adults in North America are cataract, ARM, glaucoma, and diabetic retinopathy. Even in their moderate stages, these conditions cause visual sensory impairments and reductions in health-related quality of life, including difficulties in daily tasks and psychosocial problems. Many older adults are free from these conditions, yet still experience a variety of visual perceptual problems resulting from aging-related changes in the optics of the eye and degeneration of the visual neural pathways. These problems consist of impairments in visual acuity, contrast sensitivity, color discrimination, temporal sensitivity, motion perception, peripheral visual field sensitivity, and visual processing speed. PD causes a progressive loss of dopaminergic cells predominantly in the retina and possibly in other areas of the visual system. This retinal dopamine deficiency produces selective spatial-temporal abnormalities in retinal ganglion cell function, probably arising from altered receptive field organization in the PD retina. The cortical degeneration characteristics of AD, including neurofibrillary tangles and neuritic plaques, also are present in the visual cortical areas, especially in the visual association areas. The most prominent electrophysiologic change in AD is a delay in the P2 component of the flash VEP. Deficits in higher-order visual abilities typically are compromised in AD, including problems with visual attention, perceiving structure from motion, visual memory, visual learning, reading, and object and face perception. There have been reports of a visual variant of AD in which these types of visual problems are the initial and most prominent signs of the disease. Visual sensory impairments (e.g., contrast sensitivity or achromatopsia) also have been reported but are believed more reflective of cortical disturbances than of AD-associated optic neuropathy.

Entities:  

Mesh:

Year:  2003        PMID: 13677819     DOI: 10.1016/s0733-8619(02)00107-x

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  65 in total

1.  Age-related alterations in neurons of the mouse retina.

Authors:  Melanie A Samuel; Yifeng Zhang; Markus Meister; Joshua R Sanes
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

2.  Bingo! Externally supported performance intervention for deficient visual search in normal aging, Parkinson's disease, and Alzheimer's disease.

Authors:  Thomas M Laudate; Sandy Neargarder; Tracy E Dunne; Karen D Sullivan; Pallavi Joshi; Grover C Gilmore; Tatiana M Riedel; Alice Cronin-Golomb
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2011-11-09

3.  Association of Surgeon Age and Experience With Congenital Heart Surgery Outcomes.

Authors:  Brett R Anderson; Amelia S Wallace; Kevin D Hill; Brian C Gulack; Roland Matsouaka; Jeffrey P Jacobs; Emile A Bacha; Sherry A Glied; Marshall L Jacobs
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-07

4.  Age-related decline in VIP-positive parasympathetic nerve fibers in the human submacular choroid.

Authors:  Monica M Jablonski; Alessandro Iannaccone; Drew H Reynolds; Preston Gallaher; Shaun Allen; Xiaofei Wang; Anton Reiner
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

5.  Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.

Authors:  Ozgül Altintaş; Pervin Işeri; Berna Ozkan; Yusuf Cağlar
Journal:  Doc Ophthalmol       Date:  2007-10-26       Impact factor: 2.379

6.  Change blindness, aging, and cognition.

Authors:  Matthew Rizzo; Jondavid Sparks; Sean McEvoy; Sarah Viamonte; Ida Kellison; Shaun P Vecera
Journal:  J Clin Exp Neuropsychol       Date:  2008-12-03       Impact factor: 2.475

Review 7.  Age-related changes in the visual pathways: blame it on the axon.

Authors:  David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

8.  Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.

Authors:  Sylvia E Perez; Stephen Lumayag; Beatrix Kovacs; Elliott J Mufson; Shunbin Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

9.  Expression and subcellular location of alpha-synuclein during mouse-embryonic development.

Authors:  Shan-chuan Zhong; Xue Luo; Xing-shu Chen; Qi-yan Cai; Jing Liu; Xing-hua Chen; Zhong-xiang Yao
Journal:  Cell Mol Neurobiol       Date:  2009-11-03       Impact factor: 5.046

10.  A novel, multidisciplinary clinic for complex visual problems in older people.

Authors:  R C Han; J M Jefferis; J P Taylor; N K Archibald; M P Clarke
Journal:  Eye (Lond)       Date:  2012-10-12       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.